Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

• Main Authors: Haaland, B, Chopra, A, Acharyya, S, Fay, A.P, Lopes, G.L
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: bevacizumab; interferon; pazopanib; sunitinib; angiogenesis inhibitor; antineoplastic agent; indole derivative; monoclonal antibody; pyrimidine derivative; pyrrole derivative; sulfonamide; anemia; anorexia; Article; asthenia; cancer risk; comparative study; diarrhea; drug efficacy; drug safety; drug withdrawal; dyspnea; fatigue; fever; headache; human; hypertension; kidney carcinoma; loss of appetite; metastatic clear cell renal cell carcinoma; nausea; neutropenia; overall survival; progression free survival; proteinuria; randomized controlled trial (topic); side effect; systematic review; thrombocytopenia; thyroid disease; treatment outcome; treatment response; Carcinoma, Renal Cell; Kidney Neoplasms; meta analysis; molecularly targeted therapy; Neoplasm Metastasis; survival; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Indoles; Interferons; Molecular Targeted Therapy; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Survival Analysis
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181520
• Institution: National University of Singapore

10.1186/1471-2407-14-592